Back
G1 Therapeutics 10K Form
Sell
46
GTHX
G1 Therapeutics
Last Price:
7.16
Seasonality Move:
-14.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GTHX News And Ratings
See the #1 stock for the next 7 days that we like better than GTHX
GTHX Financial Statistics
Sales & Book Value
Annual Sales: | $82.51M |
---|---|
Cash Flow: | $-5.27M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.47 |
Price / Book: | 15.34 |
Profitability
EPS (TTM): | -0.86000 |
---|---|
Net Income (TTM): | $-44.77M |
Gross Margin: | $75.32M |
Return on Equity: | -118.89% |
Return on Assets: | -37.11% |
G1 Therapeutics Earnings Forecast
Key G1 Therapeutics Financial Ratios
- The Gross Profit Margin over the past 5 years for GTHX is 91.28%.
- The Selling, General & Administrative Expenses for GTHX have been equal to 86.21% of Gross Profit Margin.
- The Research & Development expenses have been 52.98% of Revenue.
- The Interest Expense is -20.93% of Operating Income.
- The Net Earning history of GTHX is -58.13% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 4 years.
G1 Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | GTHX |
CUSIP: | 3621LQ |
Website: | g1therapeutics.com |
Debt
Debt-to-Equity Ratio: | 1.8 |
---|---|
Current Ratio: | 2.48 |
Quick Ratio: | 1.97 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 2860 |
GTHX Technical Analysis vs Fundamental Analysis
Sell
46
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics a Buy or a Sell?
-
G1 Therapeutics stock is rated a Sell
The current G1 Therapeutics [GTHX] share price is $7.15. The Score for GTHX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.